Fingerprint
Dive into the research topics of 'Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of capecitabine single-agent therapy in patients with metastatic renal cell carcinoma
Lance C. Pagliaro, Cherie A. Perez, Shi Ming Tu, Danai D. Daliani
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations